Our leadership team, including recognized physician experts and researchers, is at the forefront of shaping new standards of cancer care based upon the latest research. Patients are at the heart of everything we do. Sarah Cannon offers integrated cancer services, providing patients with cutting-edge treatments and upholding the highest quality care for patients from diagnosis through survivorship.
Dax Kurbegov, MD
Vice President & Physician-in-Chief of Clinical Programs
Dax Kurbegov, MD, is the vice president and physician-in-chief of clinical programs at Sarah Cannon. Dr. Kurbegov oversees Sarah Cannon’s clinical program development, ensuring consistency and quality and fostering collaboration across our global network of cancer programs. He works with clinical operations teams and tumor specific workgroups across the network for strategic development, implementation and evaluation of clinical programs and services for patients facing cancer in Sarah Cannon communities.
Dr. Kurbegov has led the development of both clinical and research programs across tumor sites for national oncology programs, focusing on strategic initiatives to improve patient outcomes. He joined Sarah Cannon from Catholic Health Initiatives in Colorado where he served as physician vice president of the national oncology service line for 50 cancer centers across the U.S.
Dr. Kurbegov received his bachelor of science from Stanford University and his medical degree from Baylor College of Medicine. He completed his internship and residency in internal medicine at University of Colorado Health Sciences Center and his medical oncology fellowship from The University of Texas MD Anderson Cancer Center. He has served as a physician advisor for the American Society of Clinical Oncology (ASCO®), and currently serves as chair of the ASCO® Research Community Forum. He has been recognized as a “Top Doc” by U.S. News & World Report, amongst many other recognitions.